Walgreens Boots Alliance, Inc. WBA will release earnings results for the second quarter, before the opening bell on Tuesday, April 8.Analysts expect the company to report quarterly earnings at 53 cents per share, down from $1.2 per share in the year-ago period. According to data from Benzinga Pro, Walgreens projects quarterly revenue at $38.0 billion, compared to $37.05 billion a year earlier.On March 6, Walgreens Boots Alliance entered an agreement to be acquired by private equity firm Sycamore Partners.Wi ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Walgreens Boots Alliance, Inc. regarding a class action lawsuit due to alleged misleading statements and regulatory violations during the specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from April 2, 2020, to January 16, 2025 [3]. - Allegations include that Walgreens engaged in widespread violations of federal law related to prescription medication dispensation and reimbursement, undermining their claims of improved regulatory compliance [3]. - The lawsuit claims that Walgreens' revenues from prescription medication sales were unsustainable due to unlawful conduct, leading to potential regulatory scrutiny and reputational harm [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of March 31, 2025, to participate in potential recovery [4]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [5]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated the company's stock value [5].

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the "Class Period"), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased Walgreens common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

NEW YORK, March 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA). Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: DEADLINE: March 31, 2025 Shareholders should not delay in registering for this class action. Register your informa ...

NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”), of the important March 31, 2025 lead plaintiff deadline. SO WHAT: If you purchased Walgreens common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...

NEW YORK, March 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/walgreens-boots- ...

Walgreens has agreed to pay $2.8 million to settle allegations that it submitted inflated prices to the Massachusetts and Georgia Medicaid programs for generic medications.The settlement agreement resolves a whistleblower, or qui tam, lawsuit alleging that the national pharmacy chain violated the federal, Massachusetts and Georgia False Claims Acts by submitting those prices, the U.S. Justice Department said in a Thursday (March 27) press release.“The United States, Massachusetts and Georgia allege that, be ...

Walgreens Boots Alliance (WBA -0.14%) may not be a publicly traded stock for much longer. The one wildcard is what will happen with Walgreens' primary care operations, and whether shareholders may get a boost from them. A $3 bump-up in value would represent a gain of 26%, if the sale would come in at $14.45. But that's by no means a guarantee. Investors may achieve a small profit, but there is still risk When a company announces an acquisition, there's usually not much of an incentive to buy it. The purchas ...

Core Viewpoint - Walgreens Boots Alliance, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its compliance with federal laws related to prescription medication [3][4]. Summary by Relevant Sections Allegations - The lawsuit claims that during the class period from April 2, 2020, to January 16, 2025, Walgreens engaged in widespread violations of federal law concerning the dispensation of prescription medication and reimbursement [3]. - It is alleged that Walgreens' revenues from prescription medication sales were unsustainable as they were derived from unlawful conduct, which could lead to increased regulatory scrutiny, civil liability, and reputational harm [3]. Class Action Details - Shareholders who purchased WBA shares during the specified class period are encouraged to register for the class action, with a deadline set for March 31, 2025 [4]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ: WBA) and certain officers.  The class action, filed in the United States District Court for the Northern District of Illinois, and docketed under 25-cv-01058, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Walgreens common stock between April 2, ...